Treatment Outcomes of the Modified Directly Observed Therapy (MDOT) Program of Infected Children Receiving HAART. Sophan, S (2006)

Treatment Outcomes of the Modified Directly Observed Therapy (MDOT) Program of Infected Children Receiving HAART. Sophan, S (2006) Treatment Outcomes of the Modified Directly Observed Therapy (MDOT) Program of Infected Children Receiving HAART 2006

Download this publication

AIDS and Social Policy in China: Harvard University Asia Center Cambridge, Massachusetts. Kaufman J, Kleinman A and Saich T (Eds.) (2006)

AIDS and Social Policy in China: Harvard University Asia Center Cambridge, Massachusetts. Kaufman J, Kleinman A and Saich T (Eds.) (2006) It is hard to avoid making grand statements when writing about AIDS and China, especially now that news magazines across the globe speak of the twenty-first century as “the Chinese century.” Even without the hyperbole, how the world’s most populous nation responds to AIDS obviously has great consequences for the future of public health. That future is, of course, difficult to predict: witness the brave hopes voiced three decades ago when the Chinese delegation took part in the signing of the famous Declaration of Alma Ata, which proclaimed the goal of “health for all by the year 2000.” That vision of the future does not look much like our present, either in China or elsewhere.

Download this publication

Ensuring the Sustainability of ARVs: Critical Issues in the Success of National ARV Treatment Programs in Asia. TREAT ASIA and amfAR (2006)

Ensuring the Sustainability of ARVs: Critical Issues in the Success of National ARV Treatment Programs in Asia. TREAT ASIA and amfAR (2006) This is a presentation on Critical Issues in the Success of National ARV Treatment Programs in Asia. The presentation was made by Director Kevin Robert Frost of TREAT Asia.

Download this publication

Management of HIV Infection and Antiretroviral Therapy in Infants and Children: A Clinical Manual. WHO and UNICEF (2006)

Management of HIV Infection and Antiretroviral Therapy in Infants and Children: A Clinical Manual. WHO and UNICEF (2006) These guidelines are based on the discussions held with health-care workers, researchers and programme managers from South-East Asia during a regional consultation organized by the World Health Organization Regional Office for South-East Asia (WHO SEARO) and the United Nations Children's Fund Regional Office for South Asia (UNICEF ROSA) in New Delhi during 2006. This consultation meeting reviewed the new data, experiences of scaling-up of pediatric ART in the Region and made recommendations for adaptation to the needs in the Region of the global WHO guidelines on Antiretroviral therapy of HIV infection in infants and children in resource-limited settings: towards universal access. To facilitate use at the country level the consultation recommended simplification of the global guidelines.

Download this publication

A Comprehensive Intervention Based on Peer Education for Injecting Drug Users in Lang Son. Ngu D, Duy N, Son NT, et al (2006)

A Comprehensive Intervention Based on Peer Education for Injecting Drug Users in Lang Son. Ngu D, Duy N, Son NT, et al (2006) This is a presentation on results obtained from the implementation of the project, "A comprehensive intervention based on peer education for injecting drug users" in Lang Son. The objective of this project is to restrain HIV/AIDS epidemic within IDUs and from this group in to community in Lamg Son.

Download this publication

Success and Failure at 24 Months of HAART in a Resource-poor Setting: Observational Cohort of 416 HIV-Treated Patients. Epicentre and Medecins Sans Frontiers (2006)

Success and Failure at 24 Months of HAART in a Resource-poor Setting: Observational Cohort of 416 HIV-Treated Patients. Epicentre and MEDECINS SANS FRONTIERS (2006) Main objective • Retrospective cohort analysis of patients who started ARV 24 + 2 months ago and followed without viral load monitoring Secondary objectives • Description of success/failure clinico-immunological criteria at 24 months and at 6, 12 and 18 months • Identification of the reasons for virological failure at 24 months • Description of resistance mutations to ARV observed at 24 months • Analysis of the observance of the patients still on ARV at 24 months • Evaluation of ARV side-effects during the 24 months of treatment • Pharmacological analysis of ARV at 24 months

Download this publication

Scaling Up Anti-Retroviral Treatment to (Injecting) Drug Users in Asia. Asian Harm Reduction Network (2005)

Scaling Up Anti-Retroviral Treatment to (Injecting) Drug Users in Asia. Asian Harm Reduction Network (2005) In light of the endorsement of the AIDS Care Watch Campaign, led by Health and Development Networks (HDN), the Asian Harm Reduction Network (AHRN) believes that addressing issues related to injecting drug use (IDU) and anti-retroviral treatment (ART) is essential in the Asian context. Notably, AHRN believes that the provision of ART for IDUs is a fairly recent area which has not received due attention and deserves more research and consideration.

Download this publication

Papua New Guinea: Establishment of Pilot HIV/AIDS Care Centers. ADB (2005)

Papua New Guinea: Establishment of Pilot HIV/AIDS Care Centers. ADB (2005) ince 1987, 9851 cases have been reported as HIV positive out of a total population of 5.4 millions (June, 2004). From consensus workshop in November, 2004, an estimated number of HIV positive among 15-49 year age group was between 45,000- 75,000 cases. Among reported case, 52.0 % were male and 48.0% were female. Heterosexual (79.9%) is the predominant mode of transmission, 93.6 % is adult. The majority of HIV/AIDS cases have been found in the National Capital District (60.8 %) and Western Highland (14,3 %) province.

Download this publication

Indonesia: Summary Country Profile for HIV/AIDS Treatment Scale up. WHO (2005)

Indonesia: Summary Country Profile for HIV/AIDS Treatment Scale up. WHO (2005) The epidemic in Indonesia is concentrated, with low infection rates in the general population and high rates among certain populations, mainly injecting drug users and sex workers in some regions. Transmission among injecting drug users has increased eight-fold since 1998, and rates are as high as 70% among injecting drug users in Jakarta in 2005 (according to Kios Atmajaya, a nongovernmental organization) and 53% in Denpasar (Bali) and 26% among sex workers in one brothel in Papua.

Download this publication

Technical Assistance to the Greater Mekong Subregion for HIV/AIDS Vulnerability and Risk Reduction among Ethnic Minority Groups through Communication Strategies. ADB (2005)

Technical Assistance to the Greater Mekong Subregion for HIV/AIDS Vulnerability and Risk Reduction among Ethnic Minority Groups through Communication Strategies. ADB (2005) Developing human resources and skills competencies is the Eighth Flagship Program under the Greater Mekong Subregion (GMS) program strategic framework. The GMS Regional Cooperation Strategy and Program (RCSP, March 2004) aims to reduce poverty through enhanced connectivity, increased competitiveness, and a greater sense of community. The RCSP emphasizes the need to take precautions against the negative impacts associated with these developments, such as communicable disease transmission, environmental degradation, and illegal trafficking. Many of these issues disproportionately affect vulnerable groups such as women, children, and ethnic minorities. At the 13th GMS Ministerial Meeting in December 2004, the GMS governments highlighted the prevention of the transmission of communicable diseases across borders, with particular attention to the developing threat of HIV/AIDS.

Download this publication

Pages

Data Dashboard
database
Highlighted publications
https://aidsdatahub.org/sites/default/files/highlight-reference/document/ESCAP_Asia_and_the_Pacific_SDG_Progress_Report_2020.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_Progress_Report_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_National_and_Subnational_HIV_Estimates_and_Projections_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_NASA_Report_2016-2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_TB_Global_Report_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-Global-AIDS-Update_Asia-Pacific_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-changing-laws-that-discriminate_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/PNG_HIV_National_Strategic_Information_2018-22.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/PNG_National_STI_and_HIV_Strategy.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-young-peoples-participation-in-community-based-responses-to-hiv_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNODC_factsheet_Ending_AIDS_by_2030_for_people_and_with_PUD_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/HRI-women-harm-reduction-2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Elective_C-section_should_not_be_routinely_recommended_to_WLHIV_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guideline_on_digital_interventions_for_health_system_strengthening_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Progress_report_on_HIV_viral_hepatitis_and_STI_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_HIV_UHC_Guide_Civil_Society_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_Annual_Report_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_HIV-related-travel-restrictions-explainer_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/HIV-and-the-Law-supplement-2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_IBBS_and_Population_size_estimates_among_FSW_2015.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal_National_Community_Led_HIV_Testing_Guidelines_2018.pdf
Calendar of events
Mar
1
(1 Mar - 1 Mar)
Mar
3
Mar
8
(8 Mar - 8 Mar)